For all media enquiries please contact Jennifer Durante, Director of Community & Engagement.
Email media@melanoma.org.au Phone 0412 798 990.
Assoc Prof Inês da Silva receives two prestigious awards in one night!
Assoc Prof Inês da Silva, Medical Oncologist & Senior Researcher at MIA, was recently presented with the inaugural 'Marie Krogh Young Women in Science Prize' and the 'NSW Premier’s Awards Outstanding Mid-Career Researcher of the Year', in recognition of her groundbreaking contributions to melanoma treatment and care.
Adjuvant vs Neoadjuvant – Further evidence for pre-surgery immunotherapy
Results of the RELATIVITY-098 clinical trial published in Nature Medicine show the presence of tumour is directly related to the effectiveness of combination immunotherapy for high risk and advanced melanoma, providing more evidence that neoadjuvant immunotherapy is the new frontier in treatment for melanoma, and other cancers.
Inspired fundraising by our dedicated community
Our inspiring community has been busy hosting and participating in varied events all to support MIA - from gourmet dinners, golf days, running challenges and events held to honour loved ones.
Beyond NADINA – The new wave of neoadjuvant clinical trials
MIA Medical Director, Professor Georgina Long AO, is leading the next group of clinical trials in the use of pre-surgery immunotherapy as life-saving treatment for melanoma. Results of one of these latest neoadjuvant immunotherapy clinical trials were today published in the prestigious Nature Medicine.
Personalising treatment options for complex lentigo maligna
Researchers have reported results from an international clinical trial assessing alternative treatment options for lentigo maligna - a non-invasive condition that commonly occurs on sun-exposed areas, particularly the face.
Global award for neoadjuvant immunotherapy
The International Neoadjuvant Melanoma Consortium (INMC), of which MIA’s Professor Long is a founder with three colleagues from MD Anderson USA, has been awarded the 2025 Society for Immunotherapy of Cancer Collaboration Award for its work in pioneering neoadjuvant immunotherapy for melanoma.
Thanks to our fit, fast and fantastic fundraisers!
Our amazing community has recently been busy lacing up their runners, going alcohol-free, celebrating milestones, and honouring loved ones, all to support MIA's goal of zero deaths from melanoma! Read more about their efforts.
Public consultation on Melanoma Clinical Guidelines
Melanoma Institute Australia and Cancer Council Australia are conducting a review of the clinical practice guidelines for the diagnosis and management of melanoma. The second phase is now available for review, by clinicians and the community, until 29 August 2025.
Akeem Alade says:
Yisa says:
Portia says: